Short- and Middle-Term Nephroprotective and Cardioprotective Effects of Pentoxifylline in Patients with Diabetic Nephropathy: A Randomized Controlled Trial
Oliva Mejía-Rodríguez(Mexican Social Security Institute), Ramón Paniagua, Miguel Angel Cuevas-Budhart(Mexican Social Security Institute), Helios Vega Gómez(Mexican Social Security Institute), Carmen Prado-Uribe(Mexican Social Security Institute), María Eugenia Galván-Plata(Mexican Social Security Institute), Marcela Ávila-Díaz(Mexican Social Security Institute), Cleto Álvarez-Aguilar
Cited by 1
Related Papers
Academic student satisfaction and perceived performance in the e-learning environment during the COVID-19 pandemic: Evidence across ten countries
|PLoS ONE|2021|186
Higher education students’ achievement emotions and their antecedents in e-learning amid COVID-19 pandemic: A multi-country survey
|Learning and Instruction|2022|60
Cardiovascular and Renal Effects of Bromocriptine in Diabetic Patients with Stage 4 Chronic Kidney Disease
|BioMed Research International|2013|25
Inflamación en hemodiálisis y su correlación con los índices neutrófilos/linfocitos y plaquetas/linfocitos
|Nefrología|2017|15
Prevalence of malnutrition-inflammation complex syndrome and its correlation with thyroid hormones in chronic haemodialysis patients
|Nefrología (English Edition)|2017|15